Celgene gaps up after raising guidance, levels to watch The stock is up nearly 4% at time of writing following the company's boost to guidance last night after the close. This puts the stock at a fresh lifetime high. Support is at the low of the session at $87.21. There are no resistance levels remaining, suggesting the stock will make a run to the $90 area. An absence of resistance at new life highs often means a run to the nearest round number.
News For CELG From The Last 14 Days
Check below for free stories on CELG the last two weeks.